
Komari Drugs Private Limited
About Komari Drugs Private Limited
Data last updated:
Komari Drugs Private Limited is a private limited company based in Kota, Rajasthan, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 17 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2004PTC020030. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sunita Tanwani and Sunil Lalwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.1 – B Kotri Gumanpura Road, Kota, Rajasthan, India – 324007.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Komari Drugs Private Limited's registered office is in Kota, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.1 – B Kotri Gumanpura Road, Kota, Rajasthan, India – 324007
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Komari Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Komari Drugs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Komari Drugs Private Limited, buy the company report.
Financials of Komari Drugs Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Komari Drugs Private Limited, buy the company report.
Board of directors of Komari Drugs Private Limited
Komari Drugs has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunita Tanwani | Director | 11 Nov 2005 | 21 Years 0 Months | Current |
| Sunil Lalwani | Director | 11 Nov 2005 | 21 Years 0 Months | Current |
| Monika Lalwani | Director | 17 Dec 2004 | 21 Years 11 Months | Current |
| Lalit Kumar Tanwani | Director | 17 Dec 2004 | 21 Years 11 Months | Current |
Auditor
Komari Drugs Private Limited is audited by D M S & COMPANY for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D M S & COMPANY | FY 2024 | 001169C |
Shareholding
The shareholding of Komari Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Komari Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Komari Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Komari Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Komari Drugs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Komari Drugs Private Limited, buy the company report.
Recent activity
Komari Drugs Private Limited has 4 board changes on record since 2004: 4 appointments. The latest: Sunil Lalwani was appointed as Director on 11 Nov 2005.
Frequently asked questions
Komari Drugs is an active private limited company based in Kota, Rajasthan, India. The company works in wholesale, within the trading industry. It was incorporated on 17 December 2004 (22+ years old) and is registered under CIN U24232RJ2004PTC020030.
Komari Drugs has 4 current directors:
- Sunita Tanwani - Director
- Sunil Lalwani - Director
- Monika Lalwani - Director
- Lalit Kumar Tanwani - Director
The latest financial statements of Komari Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Komari Drugs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Komari Drugs is U24232RJ2004PTC020030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Komari Drugs was incorporated on 17 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Jaipur.
Sunil Lalwani was appointed as Director on 11 Nov 2005. Sunita Tanwani was appointed as Director on 11 Nov 2005. Lalit Kumar Tanwani was appointed as Director on 17 Dec 2004. Komari Drugs has 4 board changes on record in total.
The registered office of Komari Drugs is at Plot No.1 – B Kotri Gumanpura Road, Kota, Rajasthan, India – 324007.
Komari Drugs operates in the trading industry, in the wholesale segment.
The compliance status of Komari Drugs is compliant as of 18 September 2026. The company is actively filing with the Registrar of Companies.

